The FDA has approved Wegovy HD, a higherdose formulation of Novo Nordisks Wegovy (semaglutide), marking the fourth product cleared under its Commissioners National Priority Voucher (CNPV) pilot program, which is an accelerated review pathway designed to shorten review timelines for therapies aligned with national health priorities
Most tirzepatide-related body aches resolve within 2-4 weeks of onset, particularly when the underlying causes are actively addressed with proper hydration, electrolyte supplementation, and adequate protein intake
Finding the Right Balance The journey to a healthier weight is rarely about a single pill or a single spice
Comparative Efficacy: Weight Loss Outcomes (SURMOUNT vs STEP) There are no published head-to-head clinical trials comparing semaglutide and tirzepatide directly
Bjorklund was forced to visit the emergency room several times and was hospitalized with symptoms that included stomach pain, gastrointestinal burning and throwing up whole food only hours after eating